What Transformation Has the Insulin Patch Pumps Market Undergone?
The insulin patch pumps market has seen considerable growth due to a variety of factors.
• In the past few years, the market size for insulin patch pumps has seen accelerated growth. Projections indicate that this market would rise from $1.42 billion in 2024 to approximately $1.57 billion in 2025, with a compound annual growth rate (CAGR) of 10.2%.
The substantial growth during the historic period is a consequence of several factors including the rise in diabetes cases, preference of patients for non-invasive delivery methods, an upsurge in the elderly population, heightened safety issues, as well as miniaturization and enhancements in form factors.
How Will The Insulin Patch Pumps Market Size Evolve In The Foreseeable Future?
The insulin patch pumps market is expected to maintain its strong growth trajectory in upcoming years.
• In the ensuing years, the insulin patch pumps market is projected to experience swift expansion. Its anticipated size is $2.37 billion in 2029, with a compound annual growth rate (CAGR) of 10.9%.
The surge during the forecast period is due to factors such as the rising adoption of telehealth, increase in pediatric diabetes, enhancement of diabetes awareness, concerns about environment and sustainability, and escalating healthcare initiatives. The forecast period will also see trends like the use of quantum computing design tools, growing incorporation of artificial intelligence and machine learning, embracement of digital twin simulations, progress in custom ic design tools, and expansion of high-level synthesis tools.
Which Key Drivers Are Propelling The Insulin Patch Pumps Market's Growth?
The global surge in diabetes is anticipated to fuel the expansion of the insulin patch pump market in the forthcoming years. Diabetes, a widespread ailment worldwide, owes its prevalence to numerous factors such as lifestyle and dietary habits. Insulin patch pumps, which allow for a hassle-free direct influx of insulin into the body, are deemed more convenient by many diabetic patients as opposed to insulin injections. The increasing occurrences of diabetes necessitate the requirement for insulin patch pumps. To exemplify, the UK's Office for Health Improvement & Disparities reported in March 2024 that between March 2022 and March 2023, there was a 22% rise in the percentage of individuals with type 1 diabetes who received all eight suggested care processes. Similarly, for type 2 diabetes, this figure saw a 21% increase. Moreover, the percentage reaching the target HbA1c levels escalated to a record 37.9%, as noted by the National Diabetes Audit (NDA). Consequently, the escalating instances of diabetes globally are expected to stimulate the insulin patch pumps market's growth.
What Are The Key Segments Within The Global Insulin Patch Pumps Market?
The insulin patch pumps market covered in this report is segmented –
1) By Type: Traditional Insulin Pumps, Smart Insulin Pump, Disposable Insulin Pumps
2) By Mode: Basal, Bolus
3) By Pump Type: Tethered Pump, Patch Pump
4) By Application: Type 1 Diabetes, Type 2 Diabetes
5) By End-User: Hospital, Clinics, Laboratories, Other End-Users
Subsegments:
1) By Traditional Insulin Pumps: Continuous Subcutaneous Insulin Infusion (CSII) Pumps, Manual Bolus Delivery Pumps
2) By Smart Insulin Pumps: Connected Insulin Pumps, Automated Insulin Delivery Systems
3) By Disposable Insulin Pumps: Pre-filled Disposable Insulin Pumps, Patch-Style Disposable Pumps
Pre-Book The Insulin Patch Pumps Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Impacting The Size Of The Insulin Patch Pumps Market?
The increasing adoption of advanced technologies in insulin patch pumps is a significant trend in the insulin patch pumps market. Enhancements such as smartphone integration and the automation of insulin delivery are being integrated into insulin patch pumps. Regular insulin pumps and continuous glucose monitors are transforming into smarter devices capable of automating insulin delivery. These upgraded devices provide user-friendly features while minimizing the need for manual intervention in insulin delivery. For example, Insulet Corporation, an innovative medical device organization based in the US, secured FDA approval for its Omnipod 5 automated insulin delivery system for individuals with type 1 diabetes who are 6 years and older in January 2022. This is the first and only automated insulin delivery system without tubes that can be controlled via a compatible smartphone. The system eliminates the need for multiple daily injections, tubes, and fingersticks, making diabetes management more convenient than ever before.
Who Are the Key Players in the Insulin Patch Pumps Market?
Major companies operating in the insulin patch pumps market include:
• Cellnovo Group SA
• Insulet Corporation
• Medtronic PLC
• Tandem Diabetes Care Inc.
• Hoffmann-La-Roche AG
• AMF Medical SA
• Abbott Laboratories Inc.
• Becton Dickinson and Company
• Braun Melsungen AG
• Cequr SA
• Debiotech SA
• DexCom Inc.
• Eoflow Co. Ltd.
• Embecta Corp.
• Hospira Inc.
• Johnson & Johnson Services Inc.
• LifeScan Inc.
• Sanofi S.A.
• Univlabs Technologies Pvt. Ltd.
• Ypsomed Holding AG
• Zealand Pharma A/S
• Bigfoot Biomedical Inc.
• Echo Therapeutics Inc.
• Glysens Inc.
• Medella Health Ltd.
• Roche Diabetes Care GmbH
• Valeritas Inc.
• 3S Corporation
• Apex Medical Devices
What are the Regional Insights into the Insulin Patch Pumps Market?
North America was the largest region in the insulin patch pumps market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the insulin patch pumps market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
